To update and integrate the recommendations for ankylosing spondylitis and the
recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial …

Crosstalk between inflammatory pathways and neurocircuits in the brain can lead to
behavioural responses, such as avoidance and alarm, that are likely to have provided early …

Objectives To update the Assessment of SpondyloArthritis international Society (ASAS)-
EULAR recommendations for the management of axial spondyloarthritis (axSpA). Methods …

Abstract Purpose of Review Ankylosing spondylitis (AS) was historically seen as a
predominantly male disease. However, more recent data showed a more homogenous sex …

Objectives To compare efficacy and safety of various doses of tofacitinib, an oral Janus
kinase inhibitor, with placebo in patients with active ankylosing spondylitis (AS, radiographic …

Context Increased concentrations of inflammatory biomarkers predict antidepressant
nonresponse, and inflammatory cytokines can sabotage and circumvent the mechanisms of …

Purpose To evaluate the efficacy and safety of adalimumab in patients with non-
radiographic axial spondyloarthritis (nr-axSpA). Methods Patients fulfilled Assessment of …

Mounting evidence reveals evident sex differences in physiology, disease presentation and
response to medication in axial SpA (axSpA). Unfortunately these data are often neglected …

Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several …

Objective To describe the frequency of treatment switching and outcomes among patients
with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in …